BLFS (BioLife Solutions) Shiller PE Ratio: (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BLFS BioLife Solutions Inc BLFS
73 GF Score
Price $34.66
GF Value $29.36
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is BioLife Solutions Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioLife Solutions  (NAS:BLFS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


BioLife Solutions Shiller PE Ratio Related Terms


BioLife Solutions Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for BioLife Solutions's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioLife Solutions Shiller PE Ratio Chart

BioLife Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BioLife Solutions Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BLFS vs AZTA, KMTS, STAA: Shiller PE Ratio Comparison

For the Medical Instruments & Supplies subindustry, BioLife Solutions's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLife Solutions Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioLife Solutions's Shiller PE Ratio falls into.


BLFS
73GF Score
BioLife Solutions Inc BLFS
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioLife Solutions Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BioLife Solutions's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, BioLife Solutions's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.91/333.9520*333.9520
=0.910

Current CPI (Jun. 2026) = 333.9520.

BioLife Solutions Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -0.080 241.428 -0.111
201612 -0.260 241.432 -0.360
201703 -0.070 243.801 -0.096
201706 -0.060 244.955 -0.082
201709 -0.030 246.819 -0.041
201712 -0.050 246.524 -0.068
201803 -0.010 249.554 -0.013
201806 0.050 251.989 0.066
201809 0.050 252.439 0.066
201812 0.040 251.233 0.053
201903 -1.030 254.202 -1.353
201906 0.020 256.143 0.026
201909 0.350 256.759 0.455
201912 0.020 256.974 0.026
202003 -0.010 258.115 -0.013
202006 -0.700 257.797 -0.907
202009 -0.040 260.280 -0.051
202012 -0.060 260.474 -0.077
202103 -0.030 264.877 -0.038
202106 0.190 271.696 0.234
202109 0.002 274.310 0.002
202112 -0.370 278.802 -0.443
202203 -0.180 287.504 -0.209
202206 -1.720 296.311 -1.938
202209 -0.240 296.808 -0.270
202212 -1.150 296.797 -1.294
202303 -0.320 301.836 -0.354
202306 -0.230 305.109 -0.252
202309 -0.670 307.789 -0.727
202312 -0.330 306.746 -0.359
202403 -0.220 312.332 -0.235
202406 -0.450 314.175 -0.478
202409 -0.040 315.301 -0.042
202412 0.260 315.605 0.275
202503 -0.010 319.799 -0.010
202506 -0.330 322.561 -0.342
202509 0.010 324.800 0.010
202512 0.220 324.054 0.227
202603 0.020 330.213 0.020
202606 0.910 333.952 0.910

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is BioLife Solutions (BLFS) Overvalued in 2026?

Based on GuruFocus' analysis, BioLife Solutions stock appears to be overvalued. The current stock price of $34.66 is trading 18.1% above its estimated GF Value™ of $29.36. GuruFocus considers BioLife Solutions to be Modestly Overvalued.

Key valuation signals for BLFS:

  • Shiller PE Ratio:
  • GF Value™: $29.36 vs. price of $34.66 (18.1% above fair value)
  • GF Score™: 73/100 with 8 warning signs

No single metric tells the full story. See the BLFS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioLife Solutions Business Description

Other Exchanges BJX1:Germany
Address 3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
73GF Score

Get the complete analysis for BLFS

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$34.66
Price
$29.36
GF Value